LepR antibody | knockout validation | Santa Cruz Biotechnology sc-8391
DOI
//dx.doi.org/10.13070/ko.en.6.1697
Date
2016-10-06

This is a knockout-validated antibody summary, based on the publication "Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

LepR  antibody | knockout validation | Santa Cruz Biotechnology sc-8391 figure 1
Figure 1. Immunoreactivity of LepR in nodose ganglia of Nav1.8/LepRfl/fl mice and WT mice. Representative image from 6 animals. From [1].
Antibody information

Company: Santa Cruz Biotechnology

Antibody: LepR

Catalog number: sc-8391

Summary: Mouse monoclonal IgG1 (kappa light chain) specific for an epitope mapping between amino acids 870-894 of short form Ob-R of mouse origin. Recommended for detection of short and long forms of Ob-R of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA. Also reactive with additional species, including canine.

Validation Method

Immunohistochemistry

Sample

nodose ganglia of Nav1.8/LepRfl/fl mice and WT mice

Primary incubation

1:100 dilution

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. de Lartigue G, Ronveaux C, Raybould H. Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. Mol Metab. 2014;3:595-607 pubmed publisher